Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial
Ciaran J. McMullan, Lea Borgi, Naomi D.L. Fisher, et al.
Clinical Journal of the American Society of Nephrology (2017) Vol. 12, Iss. 5, pp. 807-816
Open Access | Times Cited: 97

Showing 1-25 of 97 citing articles:

Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
Richard J. Johnson, George L. Bakris, Claudio Borghi, et al.
American Journal of Kidney Diseases (2018) Vol. 71, Iss. 6, pp. 851-865
Open Access | Times Cited: 533
Uric acid and cardiovascular disease
Gjin Ndrepepa
Clinica Chimica Acta (2018) Vol. 484, pp. 150-163
Closed Access | Times Cited: 404
Effects of Allopurinol on the Progression of Chronic Kidney Disease
Sunil V. Badve, Elaine M. Pascoe, Anushree Tiku, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 26, pp. 2504-2513
Open Access | Times Cited: 360
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
Thomas Bardin, Pascal Richette
BMC Medicine (2017) Vol. 15, Iss. 1
Open Access | Times Cited: 308
Hyperuricaemia and gout in cardiovascular, metabolic and kidney disease
Claudio Borghi, Enrico Agabiti‐Rosei, Richard J. Johnson, et al.
European Journal of Internal Medicine (2020) Vol. 80, pp. 1-11
Closed Access | Times Cited: 290
Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension
Masanari Kuwabara, Ichiro Hisatome, Koichiro Niwa, et al.
Hypertension (2017) Vol. 71, Iss. 1, pp. 78-86
Open Access | Times Cited: 193
Uric Acid and Hypertension: An Update With Recommendations
Laura Gabriela Sánchez‐Lozada, Bernardo Rodríguez‐Iturbe, Eric E. Kelley, et al.
American Journal of Hypertension (2020) Vol. 33, Iss. 7, pp. 583-594
Open Access | Times Cited: 161
Hyperuricemia and its related diseases: mechanisms and advances in therapy
Lin Du, Zong Yao, H. Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 98
Mechanisms and rationale for uricase use in patients with gout
Naomi Schlesinger, Fernando Perez‐Ruiz, Frédéric Lioté
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 10, pp. 640-649
Closed Access | Times Cited: 46
Urate, Blood Pressure, and Cardiovascular Disease
Dipender Gill, Alan C. Cameron, Stephen Burgess, et al.
Hypertension (2020) Vol. 77, Iss. 2, pp. 383-392
Open Access | Times Cited: 119
No causal effects of serum urate levels on the risk of chronic kidney disease: A Mendelian randomization study
Daniel M. Jordan, Hyon K. Choi, Marie Verbanck, et al.
PLoS Medicine (2019) Vol. 16, Iss. 1, pp. e1002725-e1002725
Open Access | Times Cited: 112
Asymptomatic hyperuricemia: is it really asymptomatic?
Kevin Yip, Rebecca E. Cohen, Michael H. Pillinger
Current Opinion in Rheumatology (2019) Vol. 32, Iss. 1, pp. 71-79
Closed Access | Times Cited: 104
Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care
Hyon K. Choi, Natalie McCormick, Chio Yokose
Nature Reviews Rheumatology (2021) Vol. 18, Iss. 2, pp. 97-111
Closed Access | Times Cited: 86
<p>Hyperuricemia and Hypertension: Links and Risks</p>
Douglas Stewart, Valérie S. Langlois, Damien Noone
Integrated Blood Pressure Control (2019) Vol. Volume 12, pp. 43-62
Open Access | Times Cited: 84
The Association of Excess Body Weight with Risk of ESKD Is Mediated Through Insulin Resistance, Hypertension, and Hyperuricemia
Josef Fritz, Wolfgang Brozek, Hans Concin, et al.
Journal of the American Society of Nephrology (2022) Vol. 33, Iss. 7, pp. 1377-1389
Open Access | Times Cited: 44
The clinical benefits of sodium–glucose cotransporter type 2 inhibitors in people with gout
Chio Yokose, Natalie McCormick, Abhishek Abhishek, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 4, pp. 216-231
Closed Access | Times Cited: 14
Large-scale cross-ancestry genome-wide meta-analysis of serum urate
Chamlee Cho, Beomsu Kim, Dan Say Kim, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Therapeutic value of stimulating the nitrate‐nitrite‐nitric oxide pathway to attenuate oxidative stress and restore nitric oxide bioavailability in cardiorenal disease
Mattias Carlström, Marcelo F. Montenegro
Journal of Internal Medicine (2018) Vol. 285, Iss. 1, pp. 2-18
Open Access | Times Cited: 81
Roles of hyperuricemia in metabolic syndrome and cardiac-kidney-vascular system diseases.
Hongsha Wang, Haifeng Zhang, Lin Sun, et al.
PubMed (2018) Vol. 10, Iss. 9, pp. 2749-2763
Closed Access | Times Cited: 76
Uric acid and hypertension
Benjamin De Becker, Claudio Borghi, Michel Burnier, et al.
Journal of Hypertension (2018) Vol. 37, Iss. 5, pp. 878-883
Closed Access | Times Cited: 65
Hypertension in Children: Role of Obesity, Simple Carbohydrates, and Uric Acid
Antonina Orlando, Emanuela Cazzaniga, Marco Giussani, et al.
Frontiers in Public Health (2018) Vol. 6
Open Access | Times Cited: 60
Uric Acid and Hypertension: Prognostic Role and Guide for Treatment
Federica Piani, Arrigo F.G. Cicero, Claudio Borghi
Journal of Clinical Medicine (2021) Vol. 10, Iss. 3, pp. 448-448
Open Access | Times Cited: 48
Cardiovascular risk associated with allopurinol vs. benzbromarone in patients with gout
Eun Ha Kang, Eun Hye Park, Anna Shin, et al.
European Heart Journal (2021) Vol. 42, Iss. 44, pp. 4578-4588
Open Access | Times Cited: 46
Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials
Tunlanut Sapankaew, Kunlawat Thadanipon, Narisa Ruenroengbun, et al.
BMC Nephrology (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 33
The Role of Uric Acid in Human Health: Insights from the Uricase Gene
Youssef M. Roman
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1409-1409
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top